Lijin Zhao

593 total citations · 1 hit paper
47 papers, 388 citations indexed

About

Lijin Zhao is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Lijin Zhao has authored 47 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 14 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Lijin Zhao's work include Pancreatic and Hepatic Oncology Research (5 papers), Liver Disease and Transplantation (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Lijin Zhao is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Liver Disease and Transplantation (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Lijin Zhao collaborates with scholars based in China, United States and France. Lijin Zhao's co-authors include Long Cheng, Shuguang Wang, Yunsheng Li, Yan Jiang, Rui Mu, Dan Tang, Dan Tang, Ao Yu, Feng Tian and Hu Long and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Lijin Zhao

39 papers receiving 381 citations

Hit Papers

Impact of lactate on immune cell function in the tumor mi... 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijin Zhao China 13 155 109 102 95 55 47 388
Tuo Deng China 12 229 1.5× 111 1.0× 75 0.7× 105 1.1× 103 1.9× 20 416
Muhammad Talal Sarmini United States 8 142 0.9× 108 1.0× 98 1.0× 181 1.9× 102 1.9× 29 473
Jianguo Lu China 12 258 1.7× 147 1.3× 86 0.8× 66 0.7× 83 1.5× 35 506
Tiancheng Xu China 10 257 1.7× 60 0.6× 215 2.1× 81 0.9× 76 1.4× 19 537
Lin Guan China 12 106 0.7× 48 0.4× 72 0.7× 46 0.5× 44 0.8× 24 307
Alessio Degiovanni Italy 12 121 0.8× 53 0.5× 70 0.7× 107 1.1× 85 1.5× 23 345
Hu Zhang China 9 183 1.2× 52 0.5× 115 1.1× 47 0.5× 51 0.9× 27 347
Jung Hye Choi South Korea 12 144 0.9× 84 0.8× 43 0.4× 68 0.7× 86 1.6× 41 398
Jiansi Chen China 16 216 1.4× 141 1.3× 162 1.6× 115 1.2× 134 2.4× 33 515
Yiyuan Pan China 14 202 1.3× 179 1.6× 103 1.0× 102 1.1× 77 1.4× 20 456

Countries citing papers authored by Lijin Zhao

Since Specialization
Citations

This map shows the geographic impact of Lijin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijin Zhao more than expected).

Fields of papers citing papers by Lijin Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijin Zhao. The network helps show where Lijin Zhao may publish in the future.

Co-authorship network of co-authors of Lijin Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Lijin Zhao. A scholar is included among the top collaborators of Lijin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijin Zhao. Lijin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Desheng, Wenlong Xie, Liang Yin, et al.. (2025). Comparative analysis of full-scale battery electric vehicle fire evolution under open and semi-enclosed conditions. Process Safety and Environmental Protection. 202. 107679–107679. 1 indexed citations
3.
4.
Yang, Jiali, Rui Lai, Zheng‐Jun Zhou, et al.. (2025). Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Frontiers in Immunology. 16. 1563303–1563303. 20 indexed citations breakdown →
5.
Kuang, Shuang-Yuan, et al.. (2025). The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years. Discover Oncology. 16(1). 1597–1597.
6.
Zhu, Chengpei, Shanshan Wang, Yunchao Wang, et al.. (2024). Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer. Cancer Immunology Immunotherapy. 73(12). 240–240. 1 indexed citations
7.
Zhang, Shiqing, Min Liu, & Lijin Zhao. (2024). Effects of different Chinese traditional exercises on mental health during the COVID-19 pandemic: a systematic review and meta-analysis. Frontiers in Public Health. 12. 1420035–1420035. 1 indexed citations
9.
Chen, Xingqi, et al.. (2024). Inverse association between type 2 diabetes and hepatocellular carcinoma in East Asian populations. Frontiers in Endocrinology. 14. 1308561–1308561. 1 indexed citations
10.
Qu, Rui, et al.. (2023). Endoscopic thyroidectomy via areola approach for stage T1 papillary thyroid carcinoma: feasibility, safety, and oncologic outcomes. Frontiers in Endocrinology. 14. 1212490–1212490. 1 indexed citations
11.
Zhao, Lijin, et al.. (2023). Adult focal β-cell nesidioblastosis: A case report. World Journal of Clinical Cases. 11(1). 150–156.
12.
Yu, Jie, et al.. (2023). Causal association between body mass index and autoimmune thyroiditis: evidence from Mendelian randomization. European journal of medical research. 28(1). 526–526. 6 indexed citations
13.
Zhang, Longhao, Jingnan Xue, Nan Zhang, et al.. (2023). The efficacy and safety of bevacizumab as a salvage therapy for patients with advanced hepatocellular carcinoma targeting immune tolerance.. PubMed. 13(8). 3582–3590. 2 indexed citations
14.
Xue, Jingnan, Yanyu Wang, Nan Zhang, et al.. (2022). Novel cellular therapies for hepatobiliary malignancies. Hepatobiliary & pancreatic diseases international. 21(5). 450–454. 3 indexed citations
15.
Li, Yunsheng, et al.. (2022). TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy. Diabetology & Metabolic Syndrome. 14(1). 26–26. 50 indexed citations
16.
Li, Yunsheng, et al.. (2019). Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299–3p/VEGF axis in vitro and in vivo. European Journal of Pharmacology. 860. 172536–172536. 23 indexed citations
17.
Zhao, Lijin, et al.. (2016). The function of activatable cell-penetrating peptides in human intrahepatic bile duct epithelial cells. Journal of Bioenergetics and Biomembranes. 48(6). 599–606. 2 indexed citations
18.
Zhao, Lijin & Fang Wang. (2016). Epithelial-to-mesenchymal transition and hepatolithiasis. World Chinese Journal of Digestology. 24(8). 1153–1153. 1 indexed citations
19.
Zhao, Lijin, et al.. (2010). Epithelial-Mesenchymal Transitions of Bile Duct Epithelial Cells in Primary Hepatolithiasis. Journal of Korean Medical Science. 25(7). 1066–1066. 6 indexed citations
20.
Cheng, Long, Lijin Zhao, Dajiang Li, et al.. (2010). Role of Cholangiocyte Bile Acid Transporters in Large Bile Duct Injury After Rat Liver Transplantation. Transplantation. 90(2). 127–134. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026